News
All articles
-
Aptitude Magazine, to tell the stories of us all
A magazine designed to tell all about Angelini Pharma, its stories and those of its people, its most exciting projects and best practices.
-
Angelini Pharma acquires ThermaCare® from GSK
The European Commission has approved a deal for GSK to sale its rights for ThermaCare® Heat Wraps to Angelini Pharma.
-
Inside our Amuchina Plant
We are inside the 17,000 m2 of the Amuchina plant in Casella where 38 people produces the wide-spectrum disinfectant Amuchina.
-
Angelini Pharma: Production increase with no price increase
Angelini Pharma has increased production of Amuchina at its Ancona plant and has focused the Casella factory on the production of disinfectants, outsourcing production of detergents.
-
Angelini Pharma company amongst the Top Employers Europe 2020
Angelini Pharma has obtained the Top Employers Europe 2020 certification. The certification is awarded to companies that stand out for the implementation of significant, innovative and effective personnel management practices.
-
Angelini Farmacéutica in Spain ranked among the most reputable companies
Angelini Farmacéutica takes 24 th place in the ranking of the most respected and recognised pharmaceutical companies in Spain.
-
Psychiatry Innovation Summit - Caring for Mental Health in a Digital World. Digital goes live at Angelini Pharma
The Summit brought together young and motivated psychiatrists from across Europe who are interested in digital developments and innovations in mental health.
-
Headway2020 - A new roadmap in Mental Health
Brussels, October 9th, 2019: Angelini Pharma’s international Public Affairs initiative “Headway2020 : A new roadmap in Mental Health” goes public ahead of the 27th World Mental Health Day at the European Parliament.
-
At Angelini Pharma we are transforming for the digital age
With healthcare policies, medical guidelines and not surprisingly prescriptions increasingly under scrutiny from both Health Authorities and budget holders, the goals for healthcare professional communications are rapidly changing.
-
Angelini announces close of acquisition of two Sanofi consumer healthcare products in Germany and Austria for a total of € 47 M
The acquired products include BoxaGrippal® and Heumann.
-
Angelini and Italian Red Cross together for Venezuela
Angelini supports the Italian Red Cross providing by medicines to people in Venezuela whose lives have been shattered by violence and instability.
-
Fotivda exclusive distribution in East European markets
On May 17 Angelini Pharma signed a deal with EUSA Pharma to be the exclusive distributor for Fotivda (Tivozanib), a product indicated for first line treatment of adult patients with advanced renal cell carcinoma (RCC)
-
Angelini appoints Pierluigi Antonelli as Pharma CEO
The Board of Directors of Angelini Holding S.p.A., is pleased to announce that Pierluigi Antonelli has been appointed as the new CEO of Angelini Pharma, effective March 4th, 2019.
